{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T18:24:40Z","timestamp":1720117480943},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ijantimicag.2005.07.010","type":"journal-article","created":{"date-parts":[[2005,10,24]],"date-time":"2005-10-24T14:12:38Z","timestamp":1130163158000},"page":"120-122","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S2","title":["Management of the febrile neutropenic patient"],"prefix":"10.1016","volume":"26","author":[{"given":"Juan J.","family":"Picazo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.07.010_bib1","first-page":"S9","article-title":"Management of fever of unknown origin in the neutropenic patient: the Japanese experience","volume":"68","author":"Masaoka","year":"1998","journal-title":"Int J Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.07.010_bib2","first-page":"S1","article-title":"Proceedings of the consensus meeting: Evidence-Based Recommendations on the Management of Febrile Neutropenia in Japan. Honolulu, Hawaii, 8\u20139 March 2003","volume":"39","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib3","series-title":"Management of infections in immunocompromised patients","author":"Glauser","year":"2000"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.1992.10.2.316","article-title":"Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule","volume":"10","author":"Talcott","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib5","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib7","first-page":"75","article-title":"Clinical guide for the evaluation and treatment of patients with neutropenia and fever","volume":"14","author":"Garc\u00eda Rodr\u00edguez","year":"2001","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulation leukocytes and infection in patients with acute leukaemia","volume":"61","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib9","series-title":"Infections in patients with hematologic malignancies","author":"Glauser","year":"2000"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mic.2002.129427","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"30","author":"O\u2019Grady","year":"2002","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2005.07.010_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/598624","article-title":"New trends in patient management: risk-based therapy for febrile patients with neutropenia","volume":"29","author":"Rolston","year":"1999","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T23:43:16Z","timestamp":1554248596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":11,"alternative-id":["S0924857905002037"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.07.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}